Weaknesses

● The stock is close to a major daily resistance at USD 42.99, which should be gotten rid of so as to gain new appreciation potential.

● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.

● The company is in debt and has limited leeway for investment

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 158.8 times its estimated earnings per share for the ongoing year.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.